Evidence Hub

In Vitro Drug Interactions Study of Lisinopril with Metformin

Iosr Journals, Kosisochi Chinwendu Amorha

Figshare, 2014

2 citations

Abstract

This study investigates the in vitro interactions of lisinopril with metformin which is important for the possible formulation of polypills comprising both drugs. The study was conducted using the USP apparatus II paddle method. The media used were buffer pH 1.2, 4.5, and 6.8 to simulate gastrointestinal tract pH. Lisinopril tablets (10 mg) were run in the presence of 500 mg metformin tablets and the degree of interaction was established after analyzing the dissolution samples with validated High Performance Liquid Chromatographic methods. The results indicated a statistically significant difference in the effect of lisinopril on the dissolution profile of metformin at pH 1.2, 4.5, and 6.8, with a decrease in the percentage of metformin released (p = 0.0052; p = 0.0037; and p = 0.0155, respectively). The effect of metformin on the dissolution profile of lisinopril was only statistically significant at pH 1.2 and 6.8 with an increase in the percentage of lisinopril released (p = 0.0062; p =0.0036, respectively), and no statistically significant difference at pH 4.5 (p = 0.7174).

How strong is the evidence?

Evidence Hub reads this as a dataset, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free